semaglutide available in canada approves generic from Dr. Reddy's, a G7 first enabled by Novo Nordisk's lapsed CAD$250 patent A more affordable alternative to

BIRDEM Med J 2016;6:2631

Not for injection, infusion, or clinical application.

The US Food and Drug Administration (FDA) has approved L-carnitine for the treatment and prevention of L-carnitine deficiency in people with serious kidney disease who are undergoing hemodialysis

Trace elements in human physiology and pathology

Research published in Advances in Nutrition (view study) identified the gastrointestinal tract as a prime site for polyphenol-mediated cardiometabolic protection, including stimulation of GLP-1 release

(Again, the oral dose is significantly higher than the injectable, because a lot of it is degraded in the GI tract.) Orforglipron seems to be slightly less effective